Literature DB >> 17520774

Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS).

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520774

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


× No keyword cloud information.
  16 in total

Review 1.  Annual adult health checkup: update on the Preventive Care Checklist Form(©).

Authors:  Anthony Duerksen; Vinita Dubey; Karl Iglar
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

2.  Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009.

Authors:  Jianwei Zhou; Frances Jamieson; Sharon Dolman; Linda Mn Hoang; Prasad Rawte; Raymond Sw Tsang
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 3.  Emerging vaccines: evidence and considerations for practice integration.

Authors:  Steven M Moss
Journal:  Can Fam Physician       Date:  2007-12       Impact factor: 3.275

4.  Impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia.

Authors:  Tung Siu; Wrency Tang; Meenakshi Dawar; David M Patrick
Journal:  Can J Public Health       Date:  2008 Sep-Oct

5.  Clinical images: Purpura fulminans caused by meningococcemia.

Authors:  Mukul P Agarwal; Vishal Sharma
Journal:  CMAJ       Date:  2009-10-26       Impact factor: 8.262

6.  Splenectomy: reducing the risk of infection.

Authors:  Joanne M Langley; Shelly McNeil
Journal:  CMAJ       Date:  2012-11-20       Impact factor: 8.262

7.  Letter to the editor.

Authors:  Raymond Sw Tsang; Frances B Jamieson; Brigitte Lefebvre; Rodica Gilca
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

8.  Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine, for use by Provinces and Territories.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2010-01-26

9.  UPDATE ON THE USE OF QUADRIVALENT CONJUGATE MENINGOCOCCAL VACCINES: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  This Statement Was Prepared By Dr B Warshawsky
Journal:  Can Commun Dis Rep       Date:  2013-01-02

10.  Immunogenicity and safety of a meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with one dose of bivalent and quadrivalent meningococcal polysaccharide vaccines: a phase III, controlled, randomized, and modified blind-observer study.

Authors:  Yagob Al-Mazrou; Mohamed Khalil; Helen Findlow; Helen Chadha; Valerie Bosch Castells; David R Johnson; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2012-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.